Journal of Commercial Biotechnology

Editorial: De-risking novel therapeutic development - time to stop blaming the molecule?
pp. 5-7(3)
Author: Shohet, Simon

The European biotech sector: Could it achieve more?
pp. 10-19(10)
Author: Fazeli, Sam

What to do when your technology is good but a licence is terminated
pp. 22-28(7)
Authors: Cox, Manon; Adams, Dan

Future employment in biotechnology in Germany
pp. 29-39(11)
Author: Menrad, Klaus

Human Tissue Act 2004: The age of consent arrives in the UK
pp. 40-44(5)
Authors: Johnson, Gillian; Wilson, Alex

Rethinking innovation in pharmaceutical R&D
pp. 45-49(5)
Authors: Baker, Ann; Gill, Jasween

Managing innovation in the pharmaceutical industry
pp. 50-57(8)
Authors: Schmid, Esther F; Smith, Dennis A

Taking stock in biotechnology futures
pp. 58-60(3)
Author: Jacobs, John L

Biotechnology in India: Emerging opportunities
pp. 61-66(6)
Author: Parmar, Himanshu

Marketspace: Leading therapeutic recombinant protein sales forecast and analysis to 2010
pp. 69-73(5)
Authors: Belsey, Mark J; Pavlou, Alex K

Legal and regulatory update
pp. 75-82(8)